Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Recurrent WHO Grade 2 Glioma
Total 0 results
Nothing found
Sponsors and Collaborators
Fang Deng
Vela Diagnostics
AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking
Association Gérontopôle Pierre Pfitzenmeyer
research institute on addictions
Catalyst OrthoScience
Community Blood Center of the Carolinas
Beijing Institute of Biotechnology
Ramos Injury Law Firm
Hyfe, Inc
Dr. Hanneke den Ouden, Donders Centre for Cognition, Radboud University
MedAlly Solutions Co., Ltd.
Martin W. Case
Center for Vascular Pathology, Moscow
Eucure (Beijing) Biopharma Co., Ltd
Institute For Advanced Reconstruction
Sudbury Regional Hospital
PPsanalytics
Ludwig Institute for Cancer Research
Clinical Trials BC (part of the BC Academic Health Science Network)
View Full List
Medical Conditions
Hurler–Scheie Syndrome
Gram-Negative Infections
Locally Advanced and Recurrent/Metastatic Gastric Cancer
HIV Seropositive
Leiomyosarcoma, Adult
First Impressions
Brain Derived Neurotrophic Factor Level
Improvement of Jawline Contour
Abdomen, Acute
Weather; Heat
Intracranial Hemorrhage
Luteal Support
Colon Resection
Convulsive Diseases
Noninvasive Prenatal Screening
Patients Diagnosed With Carpal Tunnel
Sexual Maturation
Blood Disease Infection
Insulin Pump, Programmable
Chronic Hemiparesis
View Full List
Drug Interventions
Metoclopramide + dexamethasone
Mepivacaine
Nimotuzumab
Injectable Insulin
Antibiotic treatment
Cefuroxime 750mg oral
Omeprazole 20mg
0% N2O
UFUR and Iressa
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
HBM4003 and Triprilimab
5-Fluoro-uracil
Erythropoietin
6% hetastarch
Prasugrel
Epirubicin hydrochloride
Paliperidone palmitate
ASP8062
IV rtPA (intravenous recombinant plasminogen activator)
Gefitinib
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Belarus
Contract Research Organizations in China
Contract Research Organizations in Czech Republic
Contract Research Organizations in France
Contract Research Organizations in Germany
Contract Research Organizations in Jamaica
Contract Research Organizations in Liberia
Contract Research Organizations in Malawi
Contract Research Organizations in Myanmar
Contract Research Organizations in Qatar
Contract Research Organizations in Russia
Contract Research Organizations in Serbia
CRO list by country
CROs in Kuwait
SGS
All CROs in Kuwait
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe